Small molecular CD4 mimics as HIV entry inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small molecular CD4 mimics as HIV entry inhibitors

Published:2011-11 Issue:22 Volume:19 Page:6735-6742
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Narumi Tetsuo,Arai Hiroshi,Yoshimura Kazuhisa,Harada Shigeyoshi,Nomura Wataru,Matsushita Shuzo,Tamamura Hirokazu

Funder

the Ministry of Education, Culture, Sports, Science, and Technology of Japan

Japanese Ministry of Health, Labor, and Welfare

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. HIV-1 entry – an expanding portal for drug discovery

2. Current Evidence and Future Directions for Targeting HIV Entry

3. HIV fusion and its inhibition

4. HIV-1 entry inhibitors: new targets, novel therapies

5. Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates;Journal of Virology;2023-01-31

2. Antiviral Effect of Saffron Compounds on the GP120 of HIV‐1: an In Silico Study;ChemistrySelect;2022-12-14

3. Therapeutic Potential of Marine Bioactive Peptides against Human Immunodeficiency Virus: Recent Evidence, Challenges, and Future Trends;Marine Drugs;2022-07-25

4. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis;ChemMedChem;2021-12-23

5. Oxamide Derivatives as Potent α ‐Glucosidase Inhibitors: Design, Synthesis, In Vitro Inhibitory Screening and In Silico Docking Studies;ChemistrySelect;2021-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3